Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

Tissue-specific endothelial cells: a promising approach for augmentation of soft tissue repair in orthopedics

Lebaschi A., Nakagawa Y., Wada S., Cong GT., Rodeo SA.

Narrative Review on Tendon Injury, Ligament Injury, published in Ann N Y Acad Sci (2017) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Ann N Y Acad Sci (2017)
Reported sample size
—
Source database
Europe PMC
PMID
29265420
PMCID
PMC6338338
DOI
10.1111/nyas.13575
Citations
11

Abstract (original English)

Biologics are playing an increasingly significant role in the practice of modern medicine and surgery in general and orthopedics in particular. Cell-based approaches are among the most important and widely used modalities in orthopedic biologics, with mesenchymal stem cells and other multi/pluripotent cells undergoing evaluation in numerous preclinical and clinical studies. On the other hand, fully differentiated endothelial cells (ECs) have been found to perform critical roles in homeostasis of visceral tissues through production of an adaptive panel of so-called "angiocrine factors." This newly discovered function of ECs renders them excellent candidates for novel approaches in cell-based biologics. Here, we present a review of the role of ECs and angiocrine factors in some visceral tissues, followed by an overview of current cell-based approaches and a discussion of the potential applications of ECs in soft tissue repair.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
VisceraEndothelial CellsAnimalsHumansCell TransplantationTissue EngineeringOrthopedicsCell DifferentiationOrgan Specificity

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research